Empagliflozin API
| Name of Product | Empagliflozin API |
|---|---|
| CAS No | 864070‑44‑0 |
| Therapeutic use:- | SGLT2 inhibitor for type 2 diabetes (also aids in heart failure and kidney protection) |
| Grade | IH |
| Form:- | API Powder |
| Status | Commercial |
Product Overview
Empagliflozin is a raw material active pharmaceutical ingredient for the manufacture of type 2 diabetes drugs.
Empagliflozin belongs to a category of drugs called SGLT2 inhibitors.
SGLT2 is the abbreviation for sodium-glucose co-transporter 2, which is a protein found in the kidneys.
The protein would otherwise draw sugar out of the urine and put it back into the blood.
By blocking the protein, Empagliflozin stops sugar from being reabsorbed.
The surplus sugar is eliminated from the body by the kidneys in urine form.
Empagliflozin’s official CAS number is 864070-44-0.
Clinical studies of empagliflozin-containing medicines have demonstrated benefits in reducing risk of heart failure and helping preserve kidney function in patients with type 2 diabetes.
The API appears as a white to off-white crystalline powder.Â
Therapeutic Applications
Specification Parameters
Packaging & Storage
Main Packaging Options:
Typical Pack Sizes:
Storage Conditions:
Why Choose Us
Actiza Pharmaceutical Pvt. Ltd, is a specialist in supplying high-quality APIs with comprehensive regulatory support.